Effect of Anemia on Hemorrhagic Complications and Mortality Following Percutaneous Coronary Intervention

This publication has 13 references indexed in Scilit:

• Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions
  The American Journal of Cardiology, 2004
• Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary RevascularizationREPLACE-2 Randomized Trial
  JAMA, 2004
• Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the controlled abciximab and device investigation to lower late angioplasty complications (cadillac) trial
  Published by Elsevier ,2004
• Anemia Is an Independent Predictor of Mortality After Percutaneous Coronary Intervention
  Journal of the American College of Cardiology, 2004
• Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary Intervention
  Circulation, 2004
• Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions
  The American Journal of Cardiology, 2004
• Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions
  The American Journal of Cardiology, 2003
• Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)
  European Heart Journal, 2003
• Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention
  JAMA, 2003
• Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
  Journal of the American College of Cardiology, 1988